Kurma Partners — 2019 Investments
1 investments dated 2019 · listed companies and verified rows first · show all
Amolyt Pharmaamolytpharma.comSeries A · Jul 2019 · $74M
Developing therapeutic peptides targeting rare endocrine diseases (past investment).
Co-investorsAndera PartnersATEM Capital FundCTI Life Sciences Fund L.P.EQT Life SciencesOctalfaSofinnova Partners+3 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.



